Dr Sahota's patent portfolios are key for any company with a serious presence in percutaneous transluminal coronary angioplasty (PTCA), vascular surgery, vascular lesions, interventional cardiology, stents, balloon catheters, and guidewires.
New York, NY (PRWEB) September 15, 2015
ICAP Patent Brokerage announces for sale patents disclosing fundamental stent, catheter, and guidewire device and procedures for percutaneous transluminal coronary angioplasty (PTCA). This portfolio is available from pioneering surgeon Dr. Harvinder Sahota as part of the 2015 Cardiovascular Auction. The brokerage continues to accept technology submissions for the auction, which will have a bidding deadline of December 10, 2015.
Dr. Harvinder Sahota M.D., FACC, FSCAI is a world-renowned physician, author, and lecturer. Known for performing the first coronary angioplasty in many parts of the world (including the US), he has also been attributed as the inventor of Perfusion Balloon Angioplasty, and holds two dozen patents in the medical space. See the inventor biography for Dr. Sahota.
“We are honored to showcase Dr. Sahota’s life-saving angioplasty patents for preventing restenosis” says Dean Becker, CEO of ICAP Patent Brokerage. “His patent portfolios are key for any company with a serious presence in percutaneous transluminal coronary angioplasty (PTCA), vascular surgery, vascular lesions, interventional cardiology, stents, balloon catheters, and guidewires.”
Following are key characteristics and benefits from Dr. Sahota’s three patent portfolios available for purchase:
In Cardio 009, Stent and Perfusion Balloon Catheter, a hexagonal stent provides a cross section with increased strength to prevent collapse of the stent and vessel after implantation, and a balloon catheter permits perfusion and flow of blood through an internal flow channel within the core of the balloon and after the balloon has been inflated.
In Cardio 010, Stent Procedure and Vascular Lesion Balloon Catheter, a stent may be expanded and a pocket is created between the stent and the vessel wall in order to prevent restenosis, and a balloon catheter membrane is inflated under low pressure to match the topography of a vascular lesion. Both surgical solutions gracefully accommodate sensitive tissues while serving to prevent restenosis.
In Cardio 011, Sterilization of Angioplasty Devices (stents, catheters, guidewires, etc.), a fundamental inspection and sterilization procedure ensures all angioplasty devices are clean prior to implantation in order to help prevent restenosis.
Dr. Sahota has participated in an Inventor Q&A Session, the audio recording of which can be found here. These sessions allow for an open, anonymous forum where buyers can gain a deep understanding of portfolio inventors and their inventions.
Sample forward or rearward citing companies include Abbott Laboratories, AngioDynamics, Inc., Asahi Kasei Corporation, Best Medical International, Inc., Boston Scientific Corporation, C.R. Bard, Inc., Cardiac Dimensions Inc, Cardiofocus Inc, Cook Group, Incorporated, Johnson & Johnson, Medtronic, Inc., Reva, Vascular Control Systems Inc, and W.L. Gore & Associates, Inc.
To learn more about the intellectual property available for sale in this portfolio:
Contact Michelle Tyler of ICAP Patent Brokerage at (312) 327-4438 or via email at michelle(at)icapip(dot)com.
If you would like to sell or auction a patent portfolio, visit our website to make a patent portfolio submission:
make a patent portfolio submission for an upcoming sealed bid event.
About ICAP Patent Brokerage
ICAP Patent Brokerage is the world's largest intellectual property brokerage and patent auction firm, leveraging the talents of experienced patent brokers to match buyers and sellers for the sale of patents and other intellectual property assets. With multiple transaction platforms and unparalleled industry knowledge, including experience with trademarks, brands, intellectual property licensing, and UCC sales, ICAP Patent Brokerage is the global leader in the transaction of intellectual property.